Advertisement
Screener

LEXICON PHARMACEUTICALS, INC. (LXRX) Market Cap

LEXICON PHARMACEUTICALS, INC. Market Cap

Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.

  • LEXICON PHARMACEUTICALS, INC. market cap for the quarter ending 2026-08-03 was $1.03B, a 166.06% increase year-over-year.
  • LEXICON PHARMACEUTICALS, INC. market cap for the quarter ending 2026-06-30 was $1.07B, a 174.67% increase year-over-year.
  • LEXICON PHARMACEUTICALS, INC. market cap for the quarter ending 2026-05-04 was $708.49M, a 178.69% increase year-over-year.
  • LEXICON PHARMACEUTICALS, INC. market cap for the quarter ending 2026-03-31 was $664.11M, a 162.45% increase year-over-year.
  • LEXICON PHARMACEUTICALS, INC. market cap for fiscal 2026 was $1.03B.
  • LEXICON PHARMACEUTICALS, INC. market cap for fiscal 2025 was $417.07M, a 55.25% increase from fiscal 2024.
  • LEXICON PHARMACEUTICALS, INC. market cap for fiscal 2024 was $268.64M.
  • LEXICON PHARMACEUTICALS, INC. market cap for fiscal 2023 was $315.95M, a 21.75% decline from fiscal 2022.
Available history
2011-08-04 to 2026-08-03
Data captured

Historical Market Cap

DateMarket Cap
2026-08-03$1.03B
2026-06-30$1.07B
2026-05-04$708.49M
2026-03-31$664.11M
2026-03-04$690.6M
2025-12-31$417.07M
2025-11-04$486.95M
2025-09-30$493.8M
2025-08-01$388.84M
2025-05-09$254.22M
2025-02-28$253.04M
2024-12-31$268.64M
2024-11-08$459.1M
2024-07-30$806.13M
2024-04-29$384.13M
2024-03-21$593.43M
2023-11-06$315.95M
2023-08-01$475.15M
2023-03-01$415.2M
2022-11-07$403.77M
2022-08-03$493.95M
2022-05-04$290.21M
2021-11-01$845.73M
2021-08-03$521.55M
2021-05-04$668.52M
2020-10-26$157.42M
2020-07-24$185.29M
2020-04-23$198.96M
2020-03-06$340.68M
2019-11-04$419.77M
2019-07-29$179.6M
2019-04-29$632.32M
2019-03-08$696.08M
2018-10-29$878.12M
2018-07-26$1.36B
2018-04-30$873.11M
2018-02-26$912.31M
2017-11-06$1.03B
2017-07-28$1.73B
2017-05-01$1.65B
2017-03-01$1.64B
2016-11-03$1.44B
2016-08-01$1.74B
2016-05-02$1.48B
2016-03-07$1.22B
2015-11-04$1.05B
2015-08-04$1.31B
2015-05-01$5.28B
2015-03-09$5.94B
2014-11-04$5.19B
2014-08-04$5.51B
2014-05-06$5.08B
2014-02-27$6.91B
2013-11-08$8.56B
2013-07-29$8.27B
2013-05-06$7B
2013-03-08$7.65B
2012-11-05$7.03B
2012-07-31$8.37B
2012-05-01$5.01B
2012-03-05$5.35B
2011-10-28$2.98B
2011-08-04$3.85B

Annual Market Cap

DateMarket Cap
2026-08-03$1.03B
2025-12-31$417.07M
2024-12-31$268.64M
2023-11-06$315.95M
2022-11-07$403.77M
2021-11-01$845.73M
2020-10-26$157.42M
2019-11-04$419.77M
2018-10-29$878.12M
2017-11-06$1.03B
2016-11-03$1.44B
2015-11-04$1.05B
2014-11-04$5.19B
2013-11-08$8.56B
2012-11-05$7.03B
2011-10-28$2.98B

Similar stocks

Stock NameCountryMarket CapPE Ratio
GYRE THERAPEUTICS, INC. (GYRE)United States$0.818B-24.71
Obsidian Therapeutics, Inc. (OBX)United States$0.829B
Immix Biopharma, Inc. (IMMX)United States$0.837B-18.44
Avalo Therapeutics, Inc. (AVTX)United States$0.842B-9.74
GERON CORP (GERN)United States$0.803B-12.14
Aclaris Therapeutics, Inc. (ACRS)United States$0.792B-9.78
Olema Pharmaceuticals, Inc. (OLMA)United States$0.790B-5.35
ARDELYX, INC. (ARDX)United States$0.857B-22.86
Wave Life Sciences, Inc. (WVE)$0.780B-5.56
Design Therapeutics, Inc. (DSGN)United States$0.766B-12.78